Treatment of Children with GH in the United States and Europe: Long-Term Follow-Up from NordiNet^® IOS and ANSWER Program

Keyphrases

• United States 100%
• United Europe 100%
• Europe 60%
• Norditropin® 40%
• Baseline Data 40%
• GH Treatment 40%
• Idiopathic Short Stature 20%
• Small-for-gestational Age 20%
• Longitudinal Observational Study 20%
• Naïve Patients 20%
• Clinical Characteristics 20%
• Turner Syndrome 20%
• Web-enabled 20%
• Treating Physicians 20%
• Early Diagnosis 20%
• Drug Dosing 20%
• Birth Timing 20%
• Risk-benefit 20%
• Noonan Syndrome 20%
• Local Practices 20%
• Prader-Willi Syndrome 20%
• GH Deficiency 20%
• Effectiveness Analysis 20%
• Related Disorders 20%
• Real-world Effectiveness 20%
• Safety Signal 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Human Growth Hormone 100%
• Cohort Study 50%
• Drug Dose 50%
• Short Stature 50%
• Small for Date Infant 50%
• Growth Hormone Deficiency 50%
• Prader Willi Syndrome 50%
• Disease 50%
• Turner Syndrome 50%
• Noonan Syndrome 50%

Psychology

• Short Stature 100%
• Turner Syndrome 100%
• Prader-Willi Syndrome 100%
• Gestational Age 100%